Literature DB >> 7497452

Cytogenetics of malignant gliomas. II. The sex chromosomes with reference to X isodisomy and the role of numerical X/Y changes.

B K Hecht1, C Turc-Carel, M Chatel, P Paquis, J Gioanni, R Attias, P Gaudray, F Hecht.   

Abstract

Sex chromosomal monosomy with total loss of an X or Y is frequently observed in malignant gliomas. Beyond that, not much is known about the behavior of the sex chromosomes in these tumors. We noted loss of the X from 3 of 13 gliomas from women (23%) compared to loss of the Y from 16 of 28 gliomas from men (57%). There were two structural rearrangements of the Y (an inversion and a translocation with chromosome 4). Most unexpectedly, clones with sex chromosome reversal were encountered in 3 cases. These XX clones in gliomas from men are perforce the consequence of Y loss coupled with X isodisomy, a nonrandom sequence of sex chromosome changes. We examined the company kept by numerical X and Y changes in clones and found that clones with numerical sex chromosome changes had fewer autosomal abnormalities, reflecting a distinct tendency to clonal separation of sex chromosome from autosomal abnormalities. We conclude that the sex chromosome changes are not a necessary part of the neoplastic process in malignant gliomas but that they must be of biologic significance to the brain since they are highly nonrandom in frequency, type, and sequence in brain cells.

Entities:  

Mesh:

Year:  1995        PMID: 7497452     DOI: 10.1016/0165-4608(95)00092-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  Sex differences in length of survival with malignant astrocytoma, but not with glioblastoma.

Authors:  S Diete; T Treuheit; K Dietzmann; U Schmidt; C W Wallesch
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

2.  Deletions on Chromosome Y and Downregulation of the SRY Gene in Tumor Tissue Are Associated with Worse Survival of Glioblastoma Patients.

Authors:  Małgorzata Łysiak; Anja Smits; Kenney Roy Roodakker; Elisabeth Sandberg; Anna Dimberg; Munila Mudaisi; Charlotte Bratthäll; Michael Strandeus; Peter Milos; Martin Hallbeck; Peter Söderkvist; Annika Malmström
Journal:  Cancers (Basel)       Date:  2021-03-31       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.